Flora-Focus® Probiotic Powder
Enterococcus faecalis EP-GA65
Offering exclusive probiotic powders for professional clients around the world .
EP-GA65 powder is a probiotic additive, containing the Enterococcusfaecalis EP-GA65 andalsoadilutioncarrier such as the glucose anhydrous etc.The Enterococcusfaecalis EP-GA65 is a bacteria with the below character:
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilloos
Order: Lactobacillales
Family: Enterococcaceae
Genus: Enterococcus
Species: E.faecalis
Enterococcusfaecalis is a nonmotile microbe, gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals,and ferments glucose without gas production, and does not produce a catalase reaction with hydrogen peroxide. It can produce a pseudocatalase reaction if grown on blood agar and a reduction of litmus milk, but does not liquefy gelatin. Also, It shows consistent growth throughout nutrient broth which is consistent with being a facultative anaerobe and catabolize a variety of energy sources including glycerol, lactate, malate, citrate, arginine, agmatine, and many keto acids. Enterococci survive very harsh environments including extremely alkaline pH (9.6) and salt concentrations.
The metabolism of the E. faecalis is mainly as:
1) Produce natural antibiotics, which is good for human/animals health, and bacteriostatic substances (bacteriocin) to inhibit the growth of pathogenic bacteria (E.coli and Salmonella) and improve the GI health.
2) Inhibit the reproduction of urease bacteria and putrefactive bacteria in the intestinal tract, reduce the content of urease and endotoxin in the intestinal tract, and reduce the content of ammonia and endotoxin in the blood.
3) Enhance the activity of macrophages, promote the immune response of animals, and increase the level of antibodies
4) Develop biofilms to adhere to the animal intestinal mucosa and reproduce, then forming a lactobacillus barrier to resist the side effects of pathogens and mycotoxins, which is bacillus, yeast and other pass- through bacteria could not work like this.
E. faecalis is also resistant to many commonly used antimicrobial agents (aminoglycosides, aztreonam, cephalosporins, clindamycin, the semisynthetic penicillins nafcillin and oxacillin, and trimethoprim-sulfamethoxa. So it can be used with some antibiotics to treat diseases. Also, it is a facultative anaerobic lactic acid bacteria and can resist bile salts, detergents, heavy metals, ethanol, azide, and desiccation and grow in the range of 10 to 45 °C and survive at temperatures of 60°C for 30 min, which is more suitable for production and application, compared with Bifidobacterial.
APPLICATIONS:
(1) Animal nutrition products
(2) Animal feed
(3) Feed starter cultures
HEALTH BENEFITS:
1) Produce Lactic acid, vitamin, enzyme and antibacterial substances.
2) Inhibit the growth of E.coli, salmonella and staphylococcus aureus.
3) Decrease the usage of antibiotics and enzyme.
4) Strengthen immune system, prevent diseases, improve disease resistance, reduces digestive tract diseases and respiratory diseases.
5) Lower concentrations of fecal ammonia, improve the breeding environment.
INGREDIENTS:
Enterococcusfaecalis EP-GA65
Carrier
STANDARD SPECIFICATION:
2.0*1011 CFU/g (200 Billion CFU/g)
Overage potency provided.
SHELF LIFE:
24 months in room storage, closed condition, avoid sunlight.
PACKAGE:
1)5kg/Aluminum foil bag
2)25kg/ Aluminum foil bag or upon requirements.
DOCUMENTATIONS
> Genetic identification. International Deposit Certificate
> Certificate of Analysis
> Stability Study Report
> Microbial Enumeration method
> MSDS
> NONE-GMO
TECHNICAL INDICATORS:
SAFETY CONCERNS:
Enterococcus spp. has long been recognised for its probiotic benefits and is widely used around the world. One of the major benefits of Enterococcus spp. is that it is uniquely suited to survive the digestive process and flourish in the gut. It promotes a balanced gut environment by competing for
resources that harmful organisms would otherwise consume and use to grow. It also competes with harmful organisms for adhesion sites - areas on the surface of cells to which other cells and molecules can bind.
However, some strains of Enterococcus spp. maybe pathogenic and harmful to humans.
1)Virulence of Enterococcus spp. is not well understood, but adhesins, haemolysin, hyaluronidase, aggression substance and gelatinase are putative virulence factors. These virulence genes maybe transferred to human endogenous strains present in the gastrointestinal tract, which may contribute to increasing the virulence factors of this genus and endogenous strains.
2) Moreover, anti-microbial resistance (AMR) to many commonly used antibiotics has been reported, and E.faecium is the leading cause of multi-drug resistant enterococcal infections in humans. E. faecium resistance is acquired by gene transfer systems, such as conjugative and non-conjugative plasmids or transposons.
3) Although, there are conflicting views and different regulatory approaches to E. faecium around the world.health authorities all over the world are closely monitoring the development of AMR, including the use of E. faecium as a probiotic in food and feed.
In the USA, bacterial species that should not be used in dietary supplements include Escherichia coli, Enterococcusfaecalis and Enterococcusfaecium.Conversely, Enterococcus spp is accepted for use in animal feed by the Association of American Feed
Control Officials (AAFCO) as a direct fed microorganism, provided the microorganism is non-toxigenic. In China, CFDA does not approve this strain to be free used in human foods but some of the OTC drugs approved are with Enterococcusfaecium in China, this strain is mainly approved for animal health or animal feed application whatever by the direct-fed microbes or via their metabolism mechanism to benefits the animals or environments.
NUTRITION FACTS
Item:
Enterococcusfaecalis EP-GA65 200Billion CFU/g |
Nutrition Facts
Energy(KJ)
Protein(g)
Fat(g)
Carbohydrate(g)
Sodium(mg) |
(per 100g)
1603
13.2
1.6
77.6
1200 |
Finally, let me introduce our company to you :
BioGrowing, headquartered in Shanghai, was founded in 2006. The production base covers an area of 36,666 square meters and has an annual capacity of 600 tons of highly active probiotics powder. It is one of the largest probiotics production bases in Asia. Its product range covers probiotic powder, starter cultures, functional food, and derivative products, widely used in food, medicine and healthcare, daily chemicals, agriculture, and many other fields.With "Reliable for a Better World" as its core value, BioGrowing is constantly committed to probiotics' research, development, and innovation, moving continuously towards the vision of a "global leading probiotics manufacturer" and providing customers with a full range of product solutions and quality services.
Audited Supplier 
){kind=link}